Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 90 | 1 | 11 | 0 | 994,20 € | 1.064,7 € | 7,09 % |
| Boston Scientific | 77 | 0 | 11 | 0 | 39,27 € | 83,22 € | 111,95 % |
| UnitedHealth Group Inc. | 77 | 3 | 13 | 0 | 366,00 € | 369,41 € | 0,93 % |
| Abbott Laboratories | 69 | 0 | 10 | 0 | 91,24 € | 114,37 € | 25,35 % |
| Gilead Sciences Inc | 65 | 0 | 5 | 0 | 112,98 € | 128,14 € | 13,42 % |
| Ionis Pharmaceuticals Inc. | 64 | 1 | 10 | 0 | 45,26 € | 79,22 € | 75,03 % |
| Insmed Inc. | 63 | 1 | 4 | 0 | 87,50 € | 173,11 € | 97,85 % |
| Neurocrine Bioscience | 61 | 0 | 9 | 0 | 144,40 € | 157,11 € | 8,80 % |
| Insulet Corp. | 60 | 1 | 3 | 0 | 143,75 € | 305,21 € | 112,32 % |
| Johnson & Johnson | 56 | 0 | 12 | 0 | 224,10 € | 227,33 € | 1,44 % |
| HCA Holdings Inc. | 55 | 2 | 8 | 2 | 344,20 € | 435,61 € | 26,56 % |
| Dexcom Inc. | 55 | 2 | 6 | 0 | 71,60 € | 75,53 € | 5,48 % |
| Alnylam Pharmace. | 47 | 0 | 7 | 0 | 179,55 € | 429,93 € | 139,45 % |
| Vertex Pharmaceuticals Inc. | 47 | 1 | 3 | 1 | 409,70 € | 467,05 € | 14,00 % |
| Regeneron Pharmaceuticals Inc. | 46 | 0 | 7 | 0 | 641,40 € | 721,37 € | 12,47 % |
| Tenet Healthcare | 44 | 0 | 12 | 0 | 220,00 € | 217,45 € | -1,16 % |
| AbbVie Inc. | 43 | 0 | 10 | 0 | 220,30 € | 228,85 € | 3,88 % |
| Biogen Inc. | 43 | 1 | 10 | 1 | 178,62 € | 200,07 € | 12,01 % |
| Jazz Pharmaceuticals plc | 41 | 0 | 5 | 0 | 224,20 € | 224,09 € | -0,05 % |
| Cytokinetics Inc. | 41 | 0 | 0 | 0 | 68,58 € | 81,13 € | 18,30 % |
| Medtronic plc | 41 | 1 | 2 | 0 | 73,44 € | 97,41 € | 32,63 % |
| Rhythm Pharmaceuticals | 36 | 1 | 2 | 0 | 91,50 € | 116,89 € | 27,75 % |
| Amgen Inc. | 36 | 2 | 2 | 0 | 333,00 € | 332,22 € | -0,24 % |
| Agilent Technologies Inc. | 33 | 0 | 0 | 0 | 118,25 € | 137,44 € | 16,23 % |
| Cigna Corp. | 32 | 0 | 0 | 0 | 252,10 € | 288,04 € | 14,26 % |